Sorrento Therapeutics Inc (NASDAQ:SRNE)

12.29
Delayed Data
As of Mar 27
 +0.44 / +3.71%
Today’s Change
3.10
Today|||52-Week Range
14.30
+22.05%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 25.00, with a high estimate of 30.00 and a low estimate of 20.00. The median estimate represents a +103.42% increase from the last price of 12.29.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.15
Sales
$4.5M
Reporting Date
Jun 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 45.24%
 
 
 
 
 
 
Growthannually 37.24%
 
 
 
 

Sales

Growthquarterly 401.85%
 
 
 
 
 
 
Growthannually 105.58%
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account